Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

Chen Liu(Kunming University of Science and Technology), Huai‐Xiang Hao(Novartis (Switzerland))
Clinical Cancer Research
October 12, 2020
Cited by 161


Related Papers